Dxcover

Private

GlasgowHealthcare & Life Scienceshttps://dxcover.com/

Last Round

VC Round

Feb 3, 2025

Total Funding Raised

$21.95M

Company Overview

Dxcover is a clinical-stage diagnostics company that provides a liquid biopsy platform using infrared spectroscopy and artificial intelligence for the early detection of multiple cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

liquid biopsymulti-cancer early detectioncancer diagnosticsinfrared spectroscopyATR-FTIRmedical AIcancer screeningprecision medicinediagnostic platformbrain tumor diagnosticsblood-based testingAI diagnosticsbiotechclinical diagnosticsMCED

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dxcover Comps

Public and private peers based on sector, stage, and business model.

Dxcover comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Dxcover Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Feb 3, 2025
VC Round	Feb 5, 2024
Grant	Feb 1, 2023
Series A	Feb 1, 2023
Seed	Mar 4, 2021
Seed	Sep 7, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Matthew J. Baker

President Chief Executive Officer, Chief Executive Officer

Executive Team

Dxcover Investors

Notable investors and investment history

Dxcover investors
Investor	Rounds
European Innovation Council Fund	Grant
University of Strathclyde	VC Round, Seed, Series A
Mercia Asset Management	Series A
Eos Advisory	Seed, VC Round, Series A
European Innovation Council Fund	Grant
Alba Equity	Seed
Social Investment Scotland (SIS) Ventures	VC Round, Seed, Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 26, 2025
Added ESMO, a medical society, as a customer.
Nov 26, 2025
Added Life Sciences Awards, a media/events startup, as a customer.

View all signals

Dxcover Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Dxcover Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Dxcover's valuation, stock price, and market status.

Firmographic Details

HeadquartersGlasgow

Employee Range31

Year Founded2016

Last FundingFeb 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.